Michael Frezza
Impact in
- Oncology top 2%
- Metal complexes synthesis and properties
- Peptidase Inhibition and Analysis
- Organic Chemistry top 5%
- Ferrocene Chemistry and Applications
- Synthesis and Characterization of Heterocyclic Compounds
- Organometallic Compounds Synthesis and Characterization
Papers in
- Oncology 10
- Metal complexes synthesis and properties 9
-
- Synthesis of β-Lactam Compounds 3
- Synthesis and Catalytic Reactions 3
- Ferrocene Chemistry and Applications 2
- Co-authors
- Q. Ping Dou (15 shared papers)Sara M. Schmitt (3 shared papers)Jyoti Kanwar (1 shared paper)Dajena Tomco (3 shared papers)S.S. Hindo (3 shared papers)Di Chen (3 shared papers)Andrew M. Davenport (1 shared paper)Vesna Milacic (4 shared papers)
- Journals
- Current Pharmaceutical Design (2 papers)Cancer Letters (1 paper)Journal of Medicinal Chemistry (1 paper)European Journal of Medicinal Chemistry (1 paper)Current Cancer Drug Targets (1 paper)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Michael Frezza
15 papers receiving 1.9k citations
Michael Frezza's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 983
- Organic Chemistry 620
- Hematology 146
- Inorganic Chemistry 192
- Molecular Biology 809
Countries citing papers authored by Michael Frezza
This map shows the geographic impact of Michael Frezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Frezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Frezza more than expected).
Fields of papers citing papers by Michael Frezza
This network shows the impact of papers produced by Michael Frezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Frezza. The network helps show where Michael Frezza may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Frezza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives Hit paper breakdown → | 2011 | 646 |
| 2 | Novel Metals and Metal Complexes as Platforms for Cancer Therapy Hit paper breakdown → | 2010 | 468 |
| 3 | 2009 | 144 | |
| 4 | 2009 | 102 | |
| 5 | 2010 | 91 | |
| 6 | 2007 | 87 | |
| 7 | 2009 | 87 | |
| 8 | 2011 | 72 | |
| 9 | 2011 | 71 | |
| 10 | 2009 | 59 | |
| 11 | 2008 | 38 | |
| 12 | 2007 | 31 | |
| 13 | Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring. | 2008 | 16 |
| 14 | 2011 | 13 | |
| 15 | 2008 | 3 |
About Michael Frezza
Michael Frezza is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Computational Theory and Mathematics and Nutrition and Dietetics, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (9 papers), Ubiquitin and proteasome pathways (5 papers), Synthesis of β-Lactam Compounds (3 papers), Synthesis and Catalytic Reactions (3 papers), Cell death mechanisms and regulation (2 papers), Computational Drug Discovery Methods (2 papers), Trace Elements in Health (2 papers) and Ferrocene Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (983 citations), Organic Chemistry (620 citations), Hematology (146 citations), Inorganic Chemistry (192 citations) and Molecular Biology (809 citations). Michael Frezza has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Q. Ping Dou, Sara M. Schmitt, Jyoti Kanwar, Dajena Tomco, S.S. Hindo, Di Chen, Andrew M. Davenport, Vesna Milacic, Di Chen and Cláudio N. Verani. Their work appears in journals such as Current Pharmaceutical Design, Cancer Letters, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.